ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 169 filers reported holding ALKERMES PLC in Q2 2020. The put-call ratio across all filers is 2.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,378,303 | +60.7% | 2,012,792 | +79.5% | 0.01% | +100.0% |
| Q2 2023 | $35,092,026 | +116.7% | 1,121,151 | +95.1% | 0.00% | +50.0% |
| Q1 2023 | $16,197,156 | -27.2% | 574,571 | -32.5% | 0.00% | -33.3% |
| Q4 2022 | $22,258,396 | +29.4% | 851,833 | +10.6% | 0.00% | +50.0% |
| Q3 2022 | $17,197,000 | -22.8% | 770,021 | +3.0% | 0.00% | -33.3% |
| Q2 2022 | $22,266,000 | -46.7% | 747,360 | -52.9% | 0.00% | -50.0% |
| Q1 2022 | $41,789,000 | +356.5% | 1,588,339 | +303.7% | 0.01% | +500.0% |
| Q4 2021 | $9,154,000 | -28.8% | 393,494 | -5.7% | 0.00% | -50.0% |
| Q3 2021 | $12,865,000 | -39.4% | 417,136 | -51.8% | 0.00% | -33.3% |
| Q2 2021 | $21,237,000 | +110.4% | 866,050 | +60.2% | 0.00% | +200.0% |
| Q1 2021 | $10,095,000 | -8.0% | 540,440 | -1.8% | 0.00% | -50.0% |
| Q4 2020 | $10,975,000 | +94.8% | 550,119 | +61.8% | 0.00% | +100.0% |
| Q3 2020 | $5,635,000 | +344.1% | 340,002 | +419.8% | 0.00% | – |
| Q2 2020 | $1,269,000 | -80.6% | 65,414 | -85.6% | 0.00% | -100.0% |
| Q1 2020 | $6,548,000 | -33.2% | 454,172 | -5.5% | 0.00% | 0.0% |
| Q4 2019 | $9,803,000 | +5.7% | 480,508 | +1.1% | 0.00% | 0.0% |
| Q3 2019 | $9,274,000 | +236.7% | 475,372 | +289.1% | 0.00% | +100.0% |
| Q2 2019 | $2,754,000 | +13.9% | 122,169 | +84.3% | 0.00% | 0.0% |
| Q1 2019 | $2,418,000 | -26.5% | 66,275 | -40.5% | 0.00% | 0.0% |
| Q4 2018 | $3,290,000 | +85.9% | 111,463 | +167.2% | 0.00% | – |
| Q3 2018 | $1,770,000 | -27.3% | 41,716 | -29.5% | 0.00% | -100.0% |
| Q2 2018 | $2,435,000 | -46.5% | 59,188 | -24.6% | 0.00% | 0.0% |
| Q1 2018 | $4,549,000 | +44.3% | 78,478 | +36.3% | 0.00% | 0.0% |
| Q4 2017 | $3,152,000 | -10.4% | 57,581 | -16.7% | 0.00% | 0.0% |
| Q3 2017 | $3,518,000 | +14.2% | 69,163 | +30.2% | 0.00% | 0.0% |
| Q2 2017 | $3,080,000 | -63.9% | 53,131 | -63.5% | 0.00% | 0.0% |
| Q1 2017 | $8,522,000 | -27.9% | 145,662 | -31.5% | 0.00% | -50.0% |
| Q4 2016 | $11,824,000 | +110.5% | 212,758 | +78.1% | 0.00% | 0.0% |
| Q3 2016 | $5,617,000 | +204.0% | 119,432 | +179.2% | 0.00% | +100.0% |
| Q2 2016 | $1,848,000 | -36.1% | 42,782 | -49.5% | 0.00% | 0.0% |
| Q1 2016 | $2,893,000 | -86.9% | 84,660 | -69.6% | 0.00% | -87.5% |
| Q4 2015 | $22,134,000 | +157.1% | 278,819 | +90.0% | 0.01% | +166.7% |
| Q3 2015 | $8,610,000 | -29.7% | 146,743 | -22.9% | 0.00% | -25.0% |
| Q2 2015 | $12,249,000 | -5.6% | 190,378 | -10.5% | 0.00% | -20.0% |
| Q1 2015 | $12,970,000 | +24.3% | 212,724 | +19.4% | 0.01% | +25.0% |
| Q4 2014 | $10,431,000 | +9.1% | 178,127 | -20.1% | 0.00% | 0.0% |
| Q3 2014 | $9,562,000 | -43.3% | 223,022 | -33.5% | 0.00% | -42.9% |
| Q2 2014 | $16,867,000 | +14.4% | 335,130 | +0.2% | 0.01% | +16.7% |
| Q1 2014 | $14,742,000 | +4.4% | 334,324 | -3.7% | 0.01% | 0.0% |
| Q4 2013 | $14,119,000 | -24.6% | 347,251 | -37.7% | 0.01% | -33.3% |
| Q3 2013 | $18,732,000 | -0.2% | 557,195 | -14.9% | 0.01% | 0.0% |
| Q2 2013 | $18,770,000 | – | 654,490 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |